Kane Biotech Provides Investor Update Following FB Dermatology Acquisition Announcement
(TSX-V:KNE),(OTC US:KNBIF),(Other OTC:KNBIF), WINNIPEG, Manitoba, Nov. 14, 2024 (GLOBE NEWSWIRE) — Kane Biotech Inc. (TSX- V:KNE; OTCQB:KNBIF) (the “Company”, “Kane Biotech”) announces today that President & CEO, Marc Edwards and Dr. Robert Huizinga, Executive Chair of Kane Biotech have released a video outlining the details and benefits to Kane Biotech and its investors of the […]